[1]
Miller, MS, C.J., Dart, MD, R.C., Katz, MD, MS, N.P. and Webster, MD, FACPM, FASAM, L.R. 2017. Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids. Journal of Opioid Management. 13, 6 (Dec. 2017), 379–389. DOI:https://doi.org/10.5055/jom.2017.0416.